Barclays Maintains Overweight on Universal Health Servs, Raises Price Target to $271
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Overweight rating on Universal Health Services (NYSE:UHS) and raises the price target from $256 to $271.
October 25, 2024 | 6:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Andrew Mok has maintained an Overweight rating on Universal Health Services and increased the price target from $256 to $271, indicating a positive outlook.
The increase in price target from $256 to $271 by Barclays suggests a positive outlook for UHS, likely leading to a short-term increase in stock price. The Overweight rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100